Evidence map›Paper›PMID 41149285›Full record

ArticleJournal of cardiovascular development and disease2025

Prescription Trends and the Role of Cardiologists in the Diagnosis and Treatment of Erectile Dysfunction.

Filip Tkaczyk, Michal Chudzik, Aleksandra M Piotrowska, Tim Stolpe, Julia Zurawska, Zbigniew Siudak

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Filip TkaczykCollegium Medicum, The Jan Kochanowski University in Kielce, 25-369 Kielce, Poland.ORCID 0000-0003-4847-8858
Michal ChudzikDepartment of Electrocardiology, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0001-8805-9688
Aleksandra M PiotrowskaCollegium Medicum, The Jan Kochanowski University in Kielce, 25-369 Kielce, Poland.ORCID 0000-0002-9799-8019
Tim StolpeCollegium Medicum, The Jan Kochanowski University in Kielce, 25-369 Kielce, Poland.
Julia ZurawskaCollegium Medicum, The Jan Kochanowski University in Kielce, 25-369 Kielce, Poland.
Zbigniew SiudakCollegium Medicum, The Jan Kochanowski University in Kielce, 25-369 Kielce, Poland.ORCID 0000-0002-8033-3977

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionErectile dysfunction (ED) is strongly associated with metabolic and cardiovascular diseases and may serve as a marker of vascular pathology. Phosphodiesterase type 5 (PDE-5) inhibitors are the mainstay of treatment. Considering this link, cardiologists and internists might be expected to play a key role in therapy initiation. PURPOSE: This study evaluated prescription patterns of PDE-5 inhibitors in Poland, focusing on physician specialization and consultation type.

methodsWe performed a retrospective analysis of electronic health records from over 300 outpatient clinics (2014-2024). Men >18 years with newly diagnosed ED were included. Data on the first prescriptions of sildenafil and tadalafil were assessed. Ethical approval was obtained.

resultsA total of 11,998 patients were identified (mean age 42 years; mean BMI 26.54 kg/m

conclusionsContrary to expectations, cardiologists and internists rarely initiate PDE-5 therapy. Prescribing is dominated by urologists despite high rates of cardiovascular comorbidities. A multidisciplinary approach incorporating metabolic and cardiovascular risk assessment is warranted.

Indexed as

cardiovascular riskerectile dysfunctionPDE-5 inhibitorsprescription patterns

Identifiers

PMID41149285
PMCPMC12564340

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.